Skip Navigation

European Heart Journal 1985 6(8):695-701;
Copyright © 1985 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by WOOD, A. J.
Right arrow Articles by DRAKE-HOLLAND, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WOOD, A. J.
Right arrow Articles by DRAKE-HOLLAND, A. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1985 The European Society of Cardiology

Mioflazine, a potentially protective drug against ischaemic damage: A study in dogs

A. J. WOOD*, K. ISTED{dagger}, J. HYND{dagger}, M. J. MAIN{ddagger}, M. I. M. NOBLE§, J. PARKER{dagger} and A. J. DRAKE-HOLLAND{ddagger},

{dagger}Department of Cardiology, St George's Hospital London SW170QT
{ddagger}Department of Medicine 1, St. Georges’s Hospital Medical School London SW17 0RE
§King Edward VII Hospital Midhurst Sussex GU29 0BL, U.K.

Received 20 November 1984; revised 21 March 1985; .

Address for correspondence: Dr A. J. Drake-Holland, Department of Medicine 1, St. Georges's Hospital Medical School, London SW17 ORE, England.

Abstract

The protective effect of intravenous mioflazinepretreatment was examined in intact dogs on cardiopulmonary bypass. The mechanical function of the left ventricle was measured by isovolumic pressure—volume relationships. Mioflazine alone had no inotropic effect. After one hour of normothermic (37°C) global ischaemia of the whole heart, no control hearts, pretreated with solvent, recovered sufficiently to support the animal‘s circulation; this was not the case with animals pretreated with mioflazine, they all survived. After the 30-min reperfusion period, the solvent (control) pretreated hearts had a significantly lower (P=0.05) systolic and higher (P = 0.001) diastolic pressure-volume curve than those given mioflazine.

Key Words: Myocardial ischaemia • protective drugs • cardio-pulmonary bypass


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.